These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3663882)

  • 1. Comparative steady state bioavailability of conventional and controlled-release formulations of albuterol.
    Powell ML; Weisberger M; Dowdy Y; Gural R; Symchowicz S; Patrick JE
    Biopharm Drug Dispos; 1987; 8(5):461-8. PubMed ID: 3663882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative bioavailability of a controlled-release albuterol formulation for twice-daily use.
    Sykes RS; Reese ME; Meyer MC; Chubb JM
    Biopharm Drug Dispos; 1988; 9(6):551-6. PubMed ID: 3228576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative biologic availability and pharmacokinetics of albuterol preparations in healthy Chinese.
    Yuan Y; Li K; Zhao F
    Ther Drug Monit; 1998 Dec; 20(6):624-7. PubMed ID: 9853977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability and pharmacokinetics of three formulations of albuterol.
    Powell ML; Weisberger M; Gural R; Chung M; Patrick JE; Radwanski E; Symchowicz SS
    J Pharm Sci; 1985 Feb; 74(2):217-9. PubMed ID: 3989697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of multiple dosage bioavailability between phenylpropanolamine controlled release suspension and conventional tablet in healthy volunteers].
    Shen YX; Xu CD; Gao XH; Lin DC; Liu GL
    Yao Xue Xue Bao; 1995; 30(2):157-60. PubMed ID: 7785434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the steady-state pharmacokinetics of immediate-release and controlled-release diltiazem tablets.
    Leeuwenkamp OR; Visscher HW; Mensink CK; Jonkman JH
    Eur J Clin Pharmacol; 1994; 46(3):243-7. PubMed ID: 8070505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease.
    Maesen FP; Smeets JJ
    Eur J Clin Pharmacol; 1986; 31(4):431-6. PubMed ID: 3816923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Charter MK; Palmer JB; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(1):49-52. PubMed ID: 2687008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative multiple dose kinetics of two formulations of indomethacin.
    Verbesselt R; Tjandramaga TB; Mullie A; De Schepper PJ; Cook T; Derouwaux C; Kramp R; Hwang S
    Eur J Clin Pharmacol; 1983; 24(4):563-8. PubMed ID: 6861873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral salbutamol controlled-release in Asian patients with asthma.
    Tan WC; Lee HS
    Eur J Clin Pharmacol; 1991; 41(5):495-6. PubMed ID: 1761082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.
    Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K
    Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.
    Kovarik JM; Noe A; Berthier S; McMahon L; Langholff WK; Marion AS; Hoyer PF; Ettenger R; Rordorf C
    J Clin Pharmacol; 2003 Feb; 43(2):141-7. PubMed ID: 12616666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state bioavailability of controlled-release oxycodone in normal subjects.
    Reder RF; Oshlack B; Miotto JB; Benziger DD; Kaiko RF
    Clin Ther; 1996; 18(1):95-105. PubMed ID: 8851456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.